NAT2 and breast carcinoma: Hunter and colleagues [16], in addition to examining the association between slow acetylation status and the risk of breast cancer, for which they reported a null association, found no evidence of an interaction between recent smoking status and NAT2 acetylation status among 706 postmenopausal women (cases and controls).